Literature DB >> 1850796

Disease progression and viral genome variants in experimental feline leukemia virus-induced immunodeficiency syndrome.

J I Mullins1, E A Hoover, S L Quackenbush, P R Donahue.   

Abstract

A fatal immunodeficiency syndrome with clinical and pathologic features similar to human AIDS is inducible in cats by experimental inoculation with a specific strain of feline leukemia virus (FeLV) called FeLV-FAIDS. The course of the feline disease is characterized by an age-dependent prodromal period during which a non-disease-specific, common form of proviral DNA is detected in bone marrow. Preceding clinical onset of immunodeficiency is production of high levels of specific, pathogenic variant genomes, primarily as unintegrated viral DNA, in bone marrow. Acute immunodeficiency syndrome (survival period approximately 3 months) is associated with a short prodromal period and appearance of a characteristic variant genome (variant A) that persists at high copy number as integrated and full-length unintegrated viral DNA in bone marrow. Chronic immunodeficiency syndrome (survival greater than 1 year) is marked by a longer prodromal period, a more gradual onset of severe clinical immunosuppression, and a predominance of other variant genomes that often contain substantial internal deletions. In both forms of the disease, tissue-specific replication of certain variant viruses is noted in the bone marrow, intestine, and lymph nodes. Evidence from in vitro and in vivo virus transmission studies indicates that the appearance of FeLV-FAIDS variant viruses reflects differential replication of viral genomes pre-existing in the inoculum rather than rapid de novo evolution of new variants within each animal. These results demonstrate that retrovirus-induced immunodeficiency disease in cats can be associated with and prefigured by the amplified replication of specific viral variants in target tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850796

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  8 in total

1.  Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.

Authors:  P R Donahue; S L Quackenbush; M V Gallo; C M deNoronha; J Overbaugh; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Differential pathogenicity of two feline leukemia virus subgroup A molecular clones, pFRA and pF6A.

Authors:  A J Phipps; H Chen; K A Hayes; P Roy-Burman; L E Mathes
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.

Authors:  J L Rohn; M S Moser; S R Gwynn; D N Baldwin; J Overbaugh
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 4.  Endogenous env elements: partners in generation of pathogenic feline leukemia viruses.

Authors:  P Roy-Burman
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses.

Authors:  T A Reinhart; A K Ghosh; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins.

Authors:  B S Kristal; T A Reinhart; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro.

Authors:  K Kusumi; B Conway; S Cunningham; A Berson; C Evans; A K Iversen; D Colvin; M V Gallo; S Coutre; E G Shpaer
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.

Authors:  M L Marthas; R A Ramos; B L Lohman; K K Van Rompay; R E Unger; C J Miller; B Banapour; N C Pedersen; P A Luciw
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.